small, wristwatch device. This device has been tested extensively in clinical trials on diabetic subjects and has been shown to accurately measure blood glucose in a continual and noninvasive manner.
Ligand-binding assays are ubiquitous in biochemical research and clinical determinations. In most common assay methods, binding proceeds until an equilibrium condition has been obtained, which leads to relatively long incubation times. The requirement for separating bound from free reagents in the reaction mixture before signal detection precludes direct observation of binding events. To reduce the duration of an assay and to facilitate kinetic analysis, methods based on evanescent field technology have recently been used in assay development. These include fiber optic fluorometric sensors (1) (2) (3) and surface plasmon resonance (4 ) . Specifically, evanescent field technology is based on the observation that when light travels through a waveguide at angles approaching the critical angle for total internal reflection, an evanescent field is produced on the surface of the waveguide. This field falls off exponentially with distance from the surface and is exquisitely sensitive to the refractive indices of the waveguide surface and the medium in which the surface resides. In surface plasmon resonance, this sensitivity to refractive index is used to measure the amount of substance that binds to the waveguide surface. In evanescent field fluorometry, the field stimulates fluorophores, which become attached to the surface through specific binding interactions (2 ) . We describe here the use of evanescent fiber optic fluorometric sensors to characterize ligand binding of IgG and monovalent Fab, both specific for estrone-1-glucuronide (E1g), and of the human estrogen receptor ␣ (hER-␣) to fibers bearing E1g or the specific estrogen response element (ERE) and demonstrate the determination of apparent association and dissociation binding constants.
Fused silica optical fibers obtained from Polymicro Technologies were cleaved in 11.5-cm lengths, and the cladding was removed from a 7.0-cm portion of the fiber using Fluorinert™ (3 M). To assess the binding kinetics of IgG, Fab, and hER-␣, fibers were sensitized by a modification of the method of Bhatia et al. (5 ) . Reagents were obtained from Sigma-Aldrich unless otherwise noted. Fibers were placed in a 20 mL/L solution of 3-(mercaptopropyl)-trimethoxysilane in dry toluene for 2 h at room temperature, and then rinsed in toluene, creating a glass surface bearing thiol groups. Thiols were reacted with the heterobifunctional agent, ␥-maleimidobutyric acid-N-hydroxysuccinimide ester, 2 mmol/L in reagent alcohol for 1 h. To make E1g fibers, the succinimide ester was reacted for 1 h with 0.05 g/L casein in 20 mmol/L carbonate, pH 9.3. To prepare ERE fibers, 4 mg/L 5Ј-amino-ERE (nucleotide sequence, 5Ј GTCCAAAGTCAGGTCACAGTGAC-CTGATCAAAGTT 3Ј; Research Genetics) was substituted for the protein. E1g was activated using 1-ethyl-3-(3dimethylaminopropyl)-carbodiimide, and then incubated with casein-derivatized fibers for 1 h. After extensive washing, fibers were air-dried and stored under dessicant. For binding assays, fibers were mounted inside capillary tubes having a 1.1-mm inner diameter and 80 L final volume, and ferrules were applied to the ends to permit sample injection and continuous fluid flow through the reaction cell.
Monoclonal antibody specific for E1g was obtained from Dr. Fortune Kohen (Weizmann Institute, Rehovat, Israel). Fab was prepared by papain digestion followed by purification using protein G to remove unreacted IgG and IgG fragments. hER-␣ was prepared as described by Wittliff et al. (6 ) . Proteins were labeled with Cy5 (1,3,3,3Ј,3Ј,1Ј,1Ј-heptamethyl-indodicarbocyanine sulfonic acid; Amersham) according to manufacturer's instructions. IgG was used at a final concentration of 2 ϫ 10 Ϫ8 mol/L, and Fab was used at a final concentration of 4 ϫ 10 Ϫ8 mol/L. The concentration and affinity of hER-␣ were estimated by radioligand-binding assay (7 ) , and Cy5labeled hER-␣ was used in fiber optic assays at 5 ϫ 10 Ϫ10 mol/L. Binding of fluorophore-labeled protein to coated fibers was determined using an evanescent fiber optic fluorometer (Threefold Sensors) (8 ) . To maximize the strength of the evanescent field, the fluorometer directed light from a 637 Ϯ 2 nm laser diode into the fiber optic sensor cartridge at an angle just less than the critical angle. A holographic band-stop filter centered at 637 nm allowed the Stokes-shifted fluorescence emitted from Cy5 at wavelengths longer than 650 nm to pass with high efficiency. Light was detected by a photodiode, and the resulting currents were measured by a lock-in amplifier (model SR810; Stanford Research Systems) and collected on a computer using a program written in Labview (National Instruments).
To determine rate constants for association and dissociation, kinetic data were fitted to a mathematical model Clinical Chemistry 45, No. 9, 1999 derived under the following assumptions: (a) first order reaction kinetics applied; (b) there were no interactions between binding sites; (c) the association rate constant was much larger than the dissociation rate constant k on Ͼ Ͼ k off ; (d) the number of binding sites on the fiber was limiting; and (e) the amount of binder consumed in the reaction was small enough to ignore diffusion.
Under assumption (a), the differential equation describing the binding is:
where P represents the number of bound labeled species and the over-dot represents its time-rate of change; A represents the concentration of labeled binder in solution; B represents the effective concentration of unbound sites on the fiber; k on is the apparent association constant; and k off is the apparent dissociation constant.
Applying the other assumptions and solving Eq. 1 gives:
Off rates are fitted to a first order kinetic model that assumes negligible re-binding:
Both models were equipped with detrending terms for fitting to data. Data were fitted using the custom curve fitting functionality within DeltaGraph (DeltaPoint). As an alternative to this noncompetitive means to determine K d , a competitive binding protocol was also used to determine some binding constants for hER-␣ to various estrogenic ligands. Sensor responses were measured by incubating a solution containing the binder in the sensor cartridge for either 12.5 min (Fig. 1, A and B) or 30 (Fig. 1C ) min and collecting the fluorescent response every 5 s throughout the incubation. For dissociation measurements, incubation was followed by flowing a buffer solution over the sensor for 17.5 min (Fig. 1, A and B) or 30 (Fig. 1C ) min at 0.5 mL/min and measuring sensor response every 5 s. Nonspecific binding was minimized by including 200 mL/L fetal bovine serum in the buffer. Specificity of hER-␣ binding was established by observing the absence of response from a similar preparation of cell lysate from yeast not transfected with the her-␣ gene (not shown).
Sensorgrams refer to the real-time output of evanescent sensors (9, 10 ) . Sensorgrams for the binding of labeled IgG, Fab, and hER-␣ demonstrated monotonic association kinetics; dissociation kinetics were generally monotonic, although the slow dissociation rates made measurements susceptible to noise (Fig. 1 ). Curve fitting with the above models typically gave correlation coefficients r 2 Յ0.99, with residual errors also shown in Fig. 1 . Using this method, the apparent K d for hER-␣ to E1g fibers was 2.5 ϫ 10 Ϫ9 mol/L. For the antibody to E1g, IgG gave an apparent K d of 1.6 ϫ 10 Ϫ8 mol/L, whereas Fab gave 1.1 ϫ 10 Ϫ8 mol/L. The apparent dissociation constants determined for hER-␣ and estrogen mimics obtained from sensor data via the competitive protocol are consistent with radioligand binding data (11) (12) (13) (14) (15) . The K d values obtained using competition were as follows: estradiol-17␤, 2 ϫ 10 Ϫ10 mol/L; estrone, 2 ϫ 10 Ϫ8 mol/L; estriol, 2 ϫ 10 Ϫ8 mol/L; diethylstilbestrol, 2 ϫ 10 Ϫ9 mol/L; zearalenone, 2 ϫ 10 Ϫ8 mol/L; and tamoxifen, 2 ϫ 10 Ϫ9 mol/L. All first digits of the results obtained for the biosensor are expressed as 2 in these preliminary experiments because the solutions used to determine K ␣ consisted of concentrations of candidate estrogen mimics that were 2 times various powers of 10.
In parallel experiments, fiber optic sensors were used to observe binding of hER-␣ to the ERE. Binding data were consistent with the observed agonist or antagonist activity of the aforementioned compounds. Graphs of Ṗ vs concentration of ligand generally displayed an increase in Ṗ at low concentrations followed by a decrease in Ṗ as concentrations increased. This type of response would be expected if hER possesses multiple ligand-binding sites displaying cooperative behavior as has been reported (14, 16 ) . At low ligand concentrations, the likelihood of receptor binding only one ligand in solution dominates. When such binding occurs, a conformational change producing positive cooperativity would increase the onrate of the receptor binding to the fiber. As the concentration of ligand in solution increases, it becomes more likely that all receptor binding sites are occupied; therefore, the rate of binding to the fiber would decrease, reflecting a decreased concentration of available receptor. Thus, the data obtained with the fiber optic sensor appear to be consistent with expected results. Modern clinical practice requires small, easy-to-use, quantitative, automated near-the-patient test systems. Any new test system must match the clinical needs for faster and cost-effective technological approaches. The TECHNODISK concept addresses many of the key features required for rapid immunoanalysis, i.e., microfluidics, speed, safety, flexibility, and capability for multitest panels.
The system is a flat cylinder cassette named TECHNO-DISK composed of two plastic parts. The bottom part is a polystyrene plastic mould designed with three concentric areas separated by walls in which holes have been made that allow for the circulation of fluids from the inner area, to the middle chamber, and finally to the outer waste area. Fluid is moved between the different areas by rotation on a central drive that produces sufficient centrifugal force to allow the fluid transfers. The lid is a flexible plastic mould that closes tightly over the bottom part, forming a flat cylindrical cassette that can be turned from the bottom by the action of a peripheral drive. Two holes are punched through the plastic to allow addition of the sample and wash reagent into the middle chamber (sample hole) and the addition of fluid into the inner area of the chamber to pick up the coated microbead conjugate (inner hole). The bottom part can be moved relative to the lid to two fixed positions (clockwise and counterclockwise) that open and close valves in the cassette. In one position, holes between the inner area and middle chamber are open, and in the second position holes between the middle chamber and the waste chamber are opened. By these external actions and rotation of the system, the liquid is either held in a specific area or moved from the inner area to the middle chamber or from the middle chamber to the waste chamber. Built into the waste area is an absorbant that ensures that all the liquid is retained inside the circular cassette.
The middle chamber is coated with antibody(ies) or antigen(s) that are specific to capture the analyte in the liquid sample. The inner area receives the conjugates coated on micro beads (2-m diameter).
The procedure is as follows:
The sample to be analyzed is introduced into the device with a pipette via the sample hole. The cassette is rotated slowly to allow the sample to circulate over the whole of the middle chamber containing the specific capture sectors. The cassette is left for an optimized incubation time
